Asia-Pacific Blood Transfusion Diagnostics Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia-Pacific Blood Transfusion Diagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia-Pacific Blood Transfusion Diagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Growing need for accurate blood typing and disease screening
5.1.2 Increasing demand for blood products due to aging population

5.2 Market Opportunities

5.2.1 Development of non-invasive diagnostic solutions
5.2.2 Adoption of AI-driven diagnostic tools for blood screening

5.3 Future Trends

5.3.1 Shift towards more accurate and faster diagnostic methods
5.3.2 Growing focus on personalized transfusion medicine and diagnostics

5.4 Impact of Drivers and Restraints

6. Asia-Pacific Blood Transfusion Diagnostics Market Regional Analysis

6.1 Asia-Pacific Blood Transfusion Diagnostics Market Overview

6.2 Asia-Pacific Blood Transfusion Diagnostics Market Revenue 2020-2028 (US$ Million)

6.3 Asia-Pacific Blood Transfusion Diagnostics Market Forecast Analysis

7. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Product

7.1 Instruments & Kits

7.1.1 Overview
7.1.2 Instruments & Kits: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by Application

8.1 Blood Grouping

8.1.1 Overview
8.1.2 Blood Grouping: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Disease Screening

8.2.1 Overview
8.2.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia-Pacific Blood Transfusion Diagnostics Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Diagnostic Laboratories

9.2.1 Overview
9.2.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Blood Banks

9.3.1 Overview
9.3.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Plasma Fractionation Companies

9.4.1 Overview
9.4.2 Disease Screening: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia-Pacific Blood Transfusion Diagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
10.1.1.1.2 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
10.1.1.1.3 China: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

10.1.1.2 India: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
10.1.1.2.2 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
10.1.1.2.3 India: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

10.1.1.3 Japan: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
10.1.1.3.2 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
10.1.1.3.3 Japan: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

10.1.1.4 Australia: Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
10.1.1.4.2 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
10.1.1.4.3 Australia: Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

10.1.1.5 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Product
10.1.1.5.2 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by Application
10.1.1.5.3 Rest of Asia-Pacific : Asia-Pacific Blood Transfusion Diagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia-Pacific Blood Transfusion Diagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BAG Diagnostics GmbH

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio-Rad Laboratories, Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 DiaSorin S.p.A.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Grifols, S.A.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Immucor, Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Ortho Clinical Diagnostics (QuidelOrtho Corporation)

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Quotient Limited

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights